Lantheus Holdings, Inc. Comprehensive Income
Lantheus Holdings, Inc. (LNTH) reported Comprehensive Income of $74.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $74.73M, a 5.44% decline year-over-year.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $117.86M, a 61.89% increase year-over-year.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $54.45M.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $27.59M, a 78.96% decline year-over-year.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $233.87M, a 25.01% decline from fiscal 2024.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $311.86M, a 4.59% decline from fiscal 2023.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $326.88M, a 1097.68% increase from fiscal 2022.
- Lantheus Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $27.29M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $74.73M 10-Q · filed 2026-08-06 | $192.59M 10-Q · filed 2026-08-06 | $247.03M derived: sum of 3 quarters · filed 2026-08-06 | $274.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $117.86M 10-Q · filed 2026-05-07 | $172.30M derived: sum of 2 quarters · filed 2026-05-07 | $199.89M derived: sum of 3 quarters · filed 2026-05-07 | $278.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $54.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $82.03M derived: sum of 2 quarters · filed 2026-02-26 | $161.06M derived: sum of 3 quarters · filed 2026-08-06 | $233.87M 10-K · filed 2026-02-26 |
| 2025-09-30 | $27.59M 10-Q · filed 2025-11-06 | $106.62M derived: sum of 2 quarters · filed 2026-08-06 | $179.42M 10-Q · filed 2025-11-06 | $167.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $79.03M 10-Q · filed 2026-08-06 | $151.83M 10-Q · filed 2026-08-06 | $139.59M derived: sum of 3 quarters · filed 2026-08-06 | $270.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $72.80M 10-Q · filed 2026-05-07 | $60.56M derived: sum of 2 quarters · filed 2026-05-07 | $191.70M derived: sum of 3 quarters · filed 2026-05-07 | $253.74M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$12.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $118.90M derived: sum of 2 quarters · filed 2026-02-26 | $180.94M derived: sum of 3 quarters · filed 2026-02-26 | $311.86M 10-K · filed 2026-02-26 |
| 2024-09-30 | $131.14M 10-Q · filed 2025-11-06 | $193.18M derived: sum of 2 quarters · filed 2025-11-06 | $324.10M 10-Q · filed 2025-11-06 | $427.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $62.04M 10-Q · filed 2025-08-06 | $192.97M 10-Q · filed 2025-08-06 | $296.34M derived: sum of 3 quarters · filed 2026-02-26 | $428.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $130.93M 10-Q · filed 2025-05-07 | $234.30M derived: sum of 2 quarters · filed 2026-02-26 | $366.18M derived: sum of 3 quarters · filed 2026-02-26 | $460.73M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $103.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $235.25M derived: sum of 2 quarters · filed 2026-02-26 | $329.81M derived: sum of 3 quarters · filed 2026-02-26 | $326.88M 10-K · filed 2026-02-26 |
| 2023-09-30 | $131.87M 10-Q · filed 2024-11-06 | $226.43M derived: sum of 2 quarters · filed 2024-11-06 | $223.50M 10-Q · filed 2024-11-06 | $100.07M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $94.56M 10-Q · filed 2024-07-31 | $91.63M 10-Q · filed 2024-07-31 | -$31.81M derived: sum of 3 quarters · filed 2025-02-26 | $30.09M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$2.93M 10-Q · filed 2024-05-02 | -$126.36M derived: sum of 2 quarters · filed 2025-02-26 | -$64.46M derived: sum of 3 quarters · filed 2025-02-26 | -$20.99M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$123.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$61.54M derived: sum of 2 quarters · filed 2025-02-26 | -$18.07M derived: sum of 3 quarters · filed 2025-02-26 | $27.29M 10-K · filed 2025-02-26 |
| 2022-09-30 | $61.90M 10-Q · filed 2023-11-02 | $105.37M derived: sum of 2 quarters · filed 2023-11-02 | $150.73M 10-Q · filed 2023-11-02 | $111.17M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $43.47M 10-Q · filed 2023-08-03 | $88.83M 10-Q · filed 2023-08-03 | $49.27M derived: sum of 3 quarters · filed 2024-02-22 | $35.71M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $45.36M 10-Q · filed 2023-05-04 | $5.80M derived: sum of 2 quarters · filed 2024-02-22 | -$7.76M derived: sum of 3 quarters · filed 2024-02-22 | -$34.17M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$39.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$53.12M derived: sum of 2 quarters · filed 2024-02-22 | -$79.53M derived: sum of 3 quarters · filed 2024-02-22 | -$69.72M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$13.56M 10-Q · filed 2022-11-03 | -$39.97M derived: sum of 2 quarters · filed 2022-11-03 | -$30.16M 10-Q · filed 2022-11-03 | -$33.11M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$26.42M 10-Q · filed 2022-08-04 | -$16.60M 10-Q · filed 2022-08-04 | -$19.55M derived: sum of 3 quarters · filed 2023-02-23 | -$25.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $9.82M 10-Q · filed 2022-04-29 | $6.87M derived: sum of 2 quarters · filed 2023-02-23 | $576.00K derived: sum of 3 quarters · filed 2023-02-23 | -$6.65M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$9.24M derived: sum of 2 quarters · filed 2023-02-23 | -$16.46M derived: sum of 3 quarters · filed 2023-02-23 | -$14.56M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$6.29M 10-Q · filed 2021-11-04 | -$13.51M derived: sum of 2 quarters · filed 2021-11-04 | -$11.61M 10-Q · filed 2021-11-04 | -$1.12M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$7.22M 10-Q · filed 2021-07-28 | -$5.32M 10-Q · filed 2021-07-28 | $5.17M derived: sum of 3 quarters · filed 2022-02-24 | $9.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.90M 10-Q · filed 2021-05-04 | $12.39M derived: sum of 2 quarters · filed 2022-02-24 | $17.21M derived: sum of 3 quarters · filed 2022-02-24 | $23.71M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $15.31M derived: sum of 2 quarters · filed 2022-02-24 | $21.81M derived: sum of 3 quarters · filed 2022-02-24 | $31.82M 10-K · filed 2022-02-24 |
| 2019-09-30 | $4.82M 10-Q · filed 2020-11-05 | $11.32M derived: sum of 2 quarters · filed 2020-11-05 | $21.33M 10-Q · filed 2020-11-05 | $34.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $6.50M 10-Q · filed 2020-07-31 | $16.50M 10-Q · filed 2020-07-31 | $29.72M derived: sum of 3 quarters · filed 2021-02-25 | $38.99M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $10.01M 10-Q · filed 2020-04-30 | $23.22M derived: sum of 2 quarters · filed 2021-02-25 | $32.49M derived: sum of 3 quarters · filed 2021-02-25 | $42.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $13.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $22.48M derived: sum of 2 quarters · filed 2021-02-25 | $32.23M derived: sum of 3 quarters · filed 2021-02-25 | $40.44M 10-K · filed 2021-02-25 |
| 2018-09-30 | $9.27M 10-Q · filed 2019-10-31 | $19.02M derived: sum of 2 quarters · filed 2019-10-31 | $27.23M 10-Q · filed 2019-10-31 | $124.41M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $9.75M 10-Q · filed 2019-07-25 | $17.96M 10-Q · filed 2019-07-25 | $115.14M derived: sum of 3 quarters · filed 2020-02-25 | $123.55M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $8.21M 10-Q · filed 2019-04-30 | $105.39M derived: sum of 2 quarters · filed 2020-02-25 | $113.80M derived: sum of 3 quarters · filed 2020-02-25 | $127.38M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $97.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $105.59M derived: sum of 2 quarters · filed 2020-02-25 | $119.16M derived: sum of 3 quarters · filed 2020-02-25 | $123.30M 10-K · filed 2020-02-25 |
| 2017-09-30 | $8.41M 10-Q · filed 2018-10-30 | $21.99M derived: sum of 2 quarters · filed 2018-10-30 | $26.12M 10-Q · filed 2018-10-30 | $31.10M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $13.57M 10-Q · filed 2018-08-01 | $17.71M 10-Q · filed 2018-08-01 | $22.69M derived: sum of 3 quarters · filed 2019-02-20 | $27.58M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $4.13M 10-Q · filed 2018-05-02 | $9.12M derived: sum of 2 quarters · filed 2019-02-20 | $14.01M derived: sum of 3 quarters · filed 2019-02-20 | $21.27M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $9.87M derived: sum of 2 quarters · filed 2019-02-20 | $17.14M derived: sum of 3 quarters · filed 2019-02-20 | $27.80M 10-K · filed 2019-02-20 |
| 2016-09-30 | $4.89M 10-Q · filed 2017-11-02 | $12.15M derived: sum of 2 quarters · filed 2017-08-01 | $22.82M 10-Q · filed 2017-11-02 | $27.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $7.27M 10-Q · filed 2017-08-01 | $17.93M 10-Q · filed 2017-08-01 | $22.31M derived: sum of 3 quarters · filed 2018-02-26 | $27.25M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $10.66M 10-Q · filed 2017-05-02 | $15.04M derived: sum of 2 quarters · filed 2018-02-26 | $19.98M derived: sum of 3 quarters · filed 2018-02-26 | -$4.46M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $9.32M derived: sum of 2 quarters · filed 2018-02-26 | -$15.12M derived: sum of 3 quarters · filed 2018-02-26 | -$15.10M 10-K · filed 2018-02-26 |
| 2015-09-30 | $4.94M 10-Q · filed 2016-11-01 | -$19.50M derived: sum of 2 quarters · filed 2016-11-01 | -$19.48M 10-Q · filed 2016-11-01 | -$20.15M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$24.44M 10-Q · filed 2016-08-04 | -$24.42M 10-Q · filed 2016-08-04 | -$25.09M derived: sum of 3 quarters · filed 2017-02-23 | -$26.63M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $17.00K 10-Q · filed 2016-05-03 | -$653.00K derived: sum of 2 quarters · filed 2017-02-23 | -$2.19M derived: sum of 3 quarters · filed 2017-02-23 | -$3.22M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$2.21M derived: sum of 2 quarters · filed 2017-02-23 | -$3.24M derived: sum of 3 quarters · filed 2017-02-23 | -$4.80M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$1.54M 10-Q · filed 2015-11-04 | -$2.57M derived: sum of 2 quarters · filed 2015-11-04 | -$4.13M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | -$1.03M 10-Q · filed 2015-08-05 | -$2.59M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | -$63.28M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |